Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Oct;16(4):371–376. doi: 10.1111/j.1365-2125.1983.tb02180.x

Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly.

A J Bayer, M S Pathy, S I Ankier
PMCID: PMC1428042  PMID: 6626432

Abstract

The pharmacokinetic and some pharmacodynamic characteristics of a single oral dose of 100 mg trazodone were compared in young and elderly volunteers. The maximum plasma concentration of trazodone was similar in both age groups. The time to maximum concentration was apparently prolonged in four subjects who swallowed the capsule with a minimal volume of fluid. This may have been due to the capsule being retained in the oesophagus. The terminal phase half-life of trazodone was significantly prolonged (P less than 0.05) and area under the plasma concentration-time curve was significantly larger (P less than 0.01) in the elderly. Apparent oral clearance was significantly reduced (P less than 0.01) in the elderly. Measurement of critical flicker fusion threshold and subjective assessment of alertness using a visual analogue scale, confirmed the sedative effect of trazodone in both age groups. The elderly subjects were less alert for a longer period following drug administration than the young. The differing pharmacokinetic and pharmacodynamic characteristics of trazodone in the young and elderly may be due to an age-related reduction in hepatic drug-metabolising activity, a difference in regional distribution or a change in CNS sensitivity to the drug.

Full text

PDF
371

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Yassiri M. M., Ankier S. I., Bridges P. K. Trazodone--a new antidepressant. Life Sci. 1981 Jun 1;28(22):2449–2458. doi: 10.1016/0024-3205(81)90586-5. [DOI] [PubMed] [Google Scholar]
  2. Ankier S. I., Martin B. K., Rogers M. S., Carpenter P. K., Graham C. Trazodone--a new assay procedure and some pharmacokinetic parameters. Br J Clin Pharmacol. 1981 May;11(5):505–509. doi: 10.1111/j.1365-2125.1981.tb01157.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Castleden C. M., George C. F. The effect of ageing on the hepatic clearance of propranolol. Br J Clin Pharmacol. 1979 Jan;7(1):49–54. doi: 10.1111/j.1365-2125.1979.tb00896.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Catanese B., Lisciani R. Investigations on the absorption and distribution of trazodone or AF 1161 in rats, dogs and humans. Boll Chim Farm. 1970 Jun;109(6):369–373. [PubMed] [Google Scholar]
  5. Evans K. T., Roberts G. M. The ability of patients to swallow capsules. J Clin Hosp Pharm. 1981 Sep;6(3):207–208. doi: 10.1111/j.1365-2710.1981.tb00994.x. [DOI] [PubMed] [Google Scholar]
  6. Forbes G. B., Reina J. C. Adult lean body mass declines with age: some longitudinal observations. Metabolism. 1970 Sep;19(9):653–663. doi: 10.1016/0026-0495(70)90062-4. [DOI] [PubMed] [Google Scholar]
  7. Gerner R., Estabrook W., Steuer J., Jarvik L. Treatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind study. J Clin Psychiatry. 1980 Jun;41(6):216–220. [PubMed] [Google Scholar]
  8. Gershon S., Newton R. Lack of anticholinergic side effects with a new antidepressent--trazodone. J Clin Psychiatry. 1980 Mar;41(3):100–104. [PubMed] [Google Scholar]
  9. Gurland B. J. The comparative frequency of depression in various adult age groups. J Gerontol. 1976 May;31(3):283–292. doi: 10.1093/geronj/31.3.283. [DOI] [PubMed] [Google Scholar]
  10. Jauch R., Kopitar Z., Prox A., Zimmer A. Pharmakokinetik und Stoffwechsel von Trazodone beim Menschen. Arzneimittelforschung. 1976;26(11):2084–2089. [PubMed] [Google Scholar]
  11. Kato R., Takanaka A. Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats. Jpn J Pharmacol. 1968 Dec;18(4):389–396. doi: 10.1254/jjp.18.389. [DOI] [PubMed] [Google Scholar]
  12. Nies A., Robinson D. S., Friedman M. J., Green R., Cooper T. B., Ravaris C. L., Ives J. O. Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry. 1977 Jul;134(7):790–793. doi: 10.1176/ajp.134.7.790. [DOI] [PubMed] [Google Scholar]
  13. O'Malley K., Crooks J., Duke E., Stevenson I. H. Effect of age and sex on human drug metabolism. Br Med J. 1971 Sep 11;3(5775):607–609. doi: 10.1136/bmj.3.5775.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rodstein M., Oei L. S. Cardiovascular side effects of long-term therapy with tricyclic antidepressants in the aged. J Am Geriatr Soc. 1979 May;27(5):231–234. doi: 10.1111/j.1532-5415.1979.tb06038.x. [DOI] [PubMed] [Google Scholar]
  15. Sato T., Miwa T., Tauchi H. Age changes in the human liver of the different races. Gerontologia. 1970;16(6):368–380. doi: 10.1159/000211799. [DOI] [PubMed] [Google Scholar]
  16. Wilkinson G. R., Shand D. G. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975 Oct;18(4):377–390. doi: 10.1002/cpt1975184377. [DOI] [PubMed] [Google Scholar]
  17. Williamson J. Depression in the elderly. Age Ageing. 1978;Suppl:35–40. doi: 10.1093/ageing/7.suppl.35. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES